A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants
Clinical trial NCT03891108 · COMPLETED
Trial details
- NCT number
- NCT03891108
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-28
- Primary completion
- 2019-07-29
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.